TrialBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2024

Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical Trial.

Yan Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.